Captopril-induced Agranulocytosis in Systemic Sclerosis
- 1 February 1981
- journal article
- research article
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 11 (1) , 79-81
- https://doi.org/10.1111/j.1445-5994.1981.tb03744.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- CAPTOPRIL-ASSOCIATED AGRANULOCYTOSISThe Lancet, 1980
- LONG-TERM EFFECTS OF CAPTOPRIL (SQ14 225) ON BLOOD-PRESSURE AND HORMONE LEVELS IN ESSENTIAL HYPERTENSIONThe Lancet, 1979
- Reversal of Vascular and Renal Crises of Scleroderma by Oral Angiotensin-Converting-Enzyme BlockadeNew England Journal of Medicine, 1979
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- SQ 14,225 (D-3-MERCAPTO-2-METHYLPROPANOYL-L-PROLINE), A NOVEL ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN I-CONVERTING ENZYME1978
- Inhibition of angiotensin converting enzyme by SQ 14,225 in conscious rabbitsEuropean Journal of Pharmacology, 1977
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977